|
1
|
Kojima M, Hosoda H, Date Y, Nakazato M,
Matsuo H and Kangawa K: Ghrelin is a growth-hormone-releasing
acylated peptide from stomach. Nature. 402:656–660. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stengel A, Goebel M, Wang L and Taché Y:
Ghrelin, des-acyl ghrelin and nesfatin-1 in gastric X/A-like cells:
Role as regulators of food intake and body weight. Peptides.
31:357–369. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Davis EA, Wald HS, Suarez AN, Zubcevic J,
Liu CM, Cortella AM, Kamitakahara AK, Polson JW, Arnold M, Grill
HJ, et al: Ghrelin signaling affects feeding behavior, metabolism,
and memory through the vagus nerve. Curr Biol. 30:4510–4518.e6.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cowley MA, Smith RG, Diano S, Tschöp M,
Pronchuk N, Grove KL, Strasburger CJ, Bidlingmaier M, Esterman M,
Heiman ML, et al: The distribution and mechanism of action of
ghrelin in the CNS demonstrates a novel hypothalamic circuit
regulating energy homeostasis. Neuron. 37:649–661. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wren AM, Seal LJ, Cohen MA, Brynes AE,
Frost GS, Murphy KG, Dhillo WS, Ghatei MA and Bloom SR: Ghrelin
enhances appetite and increases food intake in humans. J Clin
Endocrinol Metab. 86:59922001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Masuda Y, Tanaka T, Inomata N, Ohnuma N,
Tanaka S, Itoh Z, Hosoda H, Kojima M and Kangawa K: Ghrelin
stimulates gastric acid secretion and motility in rats. Biochem
Biophys Res Commun. 276:905–908. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Carlini VP, Monzón ME, Varas MM,
Cragnolini AB, Schiöth HB, Scimonelli TN and de Barioglio SR:
Ghrelin increases anxiety-like behavior and memory retention in
rats. Biochem Biophys Res Commun. 299:739–743. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Steiger A: Ghrelin and sleep-wake
regulation. Am J Physiol Regul Integr Comp Physiol. 292:R573–R574.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Engevik AC, Kaji I and Goldenring JR: The
physiology of the gastric parietal cell. Physiol Rev. 100:573–602.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Korbonits M, Kojima M, Kangawa K and
Grossman AB: Presence of ghrelin in normal and adenomatous human
pituitary. Endocrine. 14:101–104. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Papotti M, Duregon E and Volante M:
Ghrelin and tumors. Endocr Dev. 25:122–134. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kojima M and Kangawa K: Ghrelin: Structure
and function. Physiol Rev. 85:495–522. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fakhry J, Stebbing MJ, Hunne B, Bayguinov
Y, Ward SM, Sasse KC, Callaghan B, McQuade RM and Furness JB:
Relationships of endocrine cells to each other and to other cell
types in the human gastric fundus and corpus. Cell Tissue Res.
376:37–49. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gribble FM and Reimann F: Enteroendocrine
cells: Chemosensors in the intestinal epithelium. Annu Rev Physiol.
78:277–299. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Choi E, Roland JT, Barlow BJ, O'Neal R,
Rich AE, Nam KT, Shi C and Goldenring JR: Cell lineage distribution
atlas of the human stomach reveals heterogeneous gland populations
in the gastric antrum. Gut. 63:1711–1720. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sykaras AG, Demenis C, Cheng L, Pisitkun
T, Mclaughlin JT, Fenton RA and Smith CP: Duodenal CCK cells from
male mice express multiple hormones including ghrelin.
Endocrinology. 155:3339–3351. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Reynaud Y, Fakhry J, Fothergill L,
Callaghan B, Ringuet M, Hunne B, Bravo DM and Furness JB: The
chemical coding of 5-hydroxytryptamine containing enteroendocrine
cells in the mouse gastrointestinal tract. Cell Tissue Res.
364:489–449. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fothergill LJ, Callaghan B, Hunne B, Bravo
DM and Furness JB: Costorage of enteroendocrine hormones evaluated
at the cell and subcellular levels in male mice. Endocrinology.
158:2113–2123. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Glass LL, Calero-Nieto FJ, Jawaid W,
Larraufie P, Kay RG, Göttgens B, Reimann F and Gribble FM:
Single-cell RNA-sequencing reveals a distinct population of
proglucagon-expressing cells specific to the mouse upper small
intestine. Mol Metab. 6:1296–1303. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fothergill LJ and Furness JB: Diversity of
enteroendocrine cells investigated at cellular and subcellular
levels: The need for a new classification scheme. Histochem Cell
Biol. 150:693–702. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Grönberg M, Tsolakis AV, Magnusson L,
Janson ET and Saras J: Distribution of obestatin and ghrelin in
human tissues: Immunoreactive cells in the gastrointestinal tract,
pancreas, and mammary glands. J Histochem Cytochem. 56:793–801.
2008. View Article : Google Scholar
|
|
22
|
Zhao Z and Sakai T: Characteristic
features of ghrelin cells in the gastrointestinal tract and the
regulation of stomach ghrelin expression and production. World J
Gastroenterol. 14:6306–6311. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Teive MB, Russi RF, Vieira DS, Teive AM,
Costa A and d'Acampora AJ: Quantitative immunohistochemical
analysis of duodenal ghrelin cells after sleeve gastrectomy in
Wistar rats. Acta Cir Bras. 27:595–599. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mehdar KM: The distribution of ghrelin
cells in the human and animal gastrointestinal tract: A review of
the evidence. Folia Morphol (Warsz). 80:225–236. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gnanapavan S, Kola B, Bustin SA, Morris
DG, McGee P, Fairclough P, Bhattacharya S, Carpenter R, Grossman AB
and Korbonits M: The tissue distribution of the mRNA of ghrelin and
subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol
Metab. 87:29882002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Santos M, Bastos P, Gonzaga S, Roriz JM,
Baptista MJ, Nogueira-Silva C, Melo-Rocha G, Henriques-Coelho T,
Roncon-Albuquerque R Jr, Leite-Moreira AF, et al: Ghrelin
expression in human and rat fetal lungs and the effect of ghrelin
administration in nitrofen-induced congenital diaphragmatic hernia.
Pediatr Res. 59:531–537. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jeffery PL, Murray RE, Yeh AH, McNamara
JF, Duncan RP, Francis GD, Herington AC and Chopin LK: Expression
and function of the ghrelin axis, including a novel preproghrelin
isoform, in human breast cancer tissues and cell lines. Endocr
Relat Cancer. 12:839–850. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yeh AH, Jeffery PL, Duncan RP, Herington
AC and Chopin LK: Ghrelin and a novel preproghrelin isoform are
highly expressed in prostate cancer and ghrelin activates
mitogen-activated protein kinase in prostate cancer. Clin Cancer
Res. 11:8295–8303. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sato T, Nakamura Y, Shiimura Y, Ohgusu H,
Kangawa K and Kojima M: Structure, regulation and function of
ghrelin. J Biochem. 151:119–128. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang JV, Ren PG, Avsian-Kretchmer O, Luo
CW, Rauch R, Klein C and Hsueh AJ: Obestatin, a peptide encoded by
the ghrelin gene, opposes ghrelin's effects on food intake.
Science. 310:996–999. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nishi Y, Yoh J, Hiejima H and Kojima M:
Structures and molecular forms of the ghrelin-family peptides.
Peptides. 32:2175–2182. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hosoda H, Kojima M, Mizushima T, Shimizu S
and Kangawa K: Structural divergence of human ghrelin.
Identification of multiple ghrelin-derived molecules produced by
post-translational processing. J Biol Chem. 278:64–70. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pemberton C, Wimalasena P, Yandle T, Soule
S and Richards M: C-terminal pro-ghrelin peptides are present in
the human circulation. Biochem Biophys Res Commun. 310:567–573.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hosoda H, Doi K, Nagaya N, Okumura H,
Nakagawa E, Enomoto M, Ono F and Kangawa K: Optimum collection and
storage conditions for ghrelin measurements: Octanoyl modification
of ghrelin is rapidly hydrolyzed to desacyl ghrelin in blood
samples. Clin Chem. 50:1077–1080. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Patterson M, Murphy KG, le Roux CW, Ghatei
MA and Bloom SR: Characterization of ghrelin-like immunoreactivity
in human plasma. J Clin Endocrinol Metab. 90:2205–2211. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ibrahim Abdalla MM: Ghrelin-physiological
functions and regulation. Eur Endocrinol. 11:90–95. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Delhanty PJ, Neggers SJ and van der Lely
AJ: Mechanisms in endocrinology: Ghrelin: The differences between
acyl- and des-acyl ghrelin. Eur J Endocrino. 167:601–608. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lanfranco F, Baldi M, Cassoni P, Bosco M,
Ghé C and Muccioli G: Ghrelin and prostate cancer. Vitam Horm.
77:301–324. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gahete MD, Córdoba-Chacón J,
Hergueta-Redondo M, Martínez-Fuentes AJ, Kineman RD, Moreno-Bueno
G, Luque RM and Castaño JP: A novel human ghrelin variant
(In1-ghrelin) and ghrelin-O-acyltransferase are overexpressed in
breast cancer: Potential pathophysiological relevance. PLoS One.
6:e233022011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gahete MD, Rincón-Fernández D, Villa-Osaba
A, Hormaechea-Agulla D, Ibáñez-Costa A, Martínez-Fuentes AJ,
Gracia-Navarro F, Castaño JP and Luque RM: Ghrelin gene products,
receptors, and GOAT enzyme: Biological and pathophysiological
insight. J Endocrinol. 220:R1–R24. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yang J, Brown MS, Liang G, Grishin NV and
Goldstein JL: Identification of the acyltransferase that
octanoylates ghrelin, an appetite-stimulating peptide hormone.
Cell. 132:387–396. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Delporte C: Structure and physiological
actions of ghrelin. Scientifica (Cairo). 2013:5189092013.PubMed/NCBI
|
|
43
|
Ferré G, Louet M, Saurel O, Delort B,
Czaplicki G, M'Kadmi C, Damian M, Renault P, Cantel S, Gavara L, et
al: Structure and dynamics of G protein-coupled receptor-bound
ghrelin reveal the critical role of the octanoyl chain. Proc Natl
Acad Sci USA. 116:17525–17530. 2019. View Article : Google Scholar
|
|
44
|
Rodríguez A, Gómez-Ambrosi J, Catalán V,
Gil MJ, Becerril S, Sáinz N, Silva C, Salvador J, Colina I and
Frühbeck G: Acylated and desacyl ghrelin stimulate lipid
accumulation in human visceral adipocytes. Int J Obes (Lond).
33:541–552. 2009. View Article : Google Scholar
|
|
45
|
Heppner KM, Piechowski CL, Müller A,
Ottaway N, Sisley S, Smiley DL, Habegger KM, Pfluger PT, Dimarchi
R, Biebermann H, et al: Both acyl and des-acyl ghrelin regulate
adiposity and glucose metabolism via central nervous system ghrelin
receptors. Diabetes. 63:122–131. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Howard AD, Feighner SD, Cully DF, Arena
JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC,
Anderson J, et al: A receptor in pituitary and hypothalamus that
functions in growth hormone release. Science. 273:974–977. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Volante M, Fulcheri E, Allìa E, Cerrato M,
Pucci A and Papotti M: Ghrelin expression in fetal, infant, and
adult human lung. J Histochem Cytochem. 50:1013–1021. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Muccioli G, Baragli A, Granata R, Papotti
M and Ghigo E: Heterogeneity of ghrelin/growth hormone secretagogue
receptors. Toward the understanding of the molecular identity of
novel ghrelin/GHS receptors. Neuroendocrinology. 86:147–164. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ueberberg B, Unger N, Saeger W, Mann K and
Petersenn S: Expression of ghrelin and its receptor in human
tissues. Horm Metab Res. 41:814–821. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Xiao X, Bi M, Jiao Q, Chen X, Du X and
Jiang H: A new understanding of GHSR1a-independent of ghrelin
activation. Ageing Res Rev. 64:1011872020. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Albarrán-Zeckler RG and Smith RG: The
ghrelin receptors (GHS-R1a and GHS-R1b). Endocr Dev. 25:5–15. 2013.
View Article : Google Scholar
|
|
52
|
Callaghan B and Furness JB: Novel and
conventional receptors for ghrelin, desacyl-ghrelin, and
pharmacologically related compounds. Pharmacol Rev. 66:984–1001.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Drucker DJ: Evolving concepts and
translational relevance of enteroendocrine cell biology. J Clin
Endocrinol Metab. 101:778–786. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Thompson NM, Gill DA, Davies R, Loveridge
N, Houston PA, Robinson IC and Wells T: Ghrelin and des-octanoyl
ghrelin promote adipogenesis directly in vivo by a mechanism
independent of the type 1a growth hormone secretagogue receptor.
Endocrinology. 145:234–242. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Churm R, Davies JS, Stephens JW and Prior
SL: Ghrelin function in human obesity and type 2 diabetes: A
concise review. Obes Rev. 18:140–148. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Toshinai K, Yamaguchi H, Sun Y, Smith RG,
Yamanaka A, Sakurai T, Date Y, Mondal MS, Shimbara T, Kawagoe T, et
al: Des-acyl ghrelin induces food intake by a mechanism independent
of the growth hormone secretagogue receptor. Endocrinology.
147:2306–2314. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Au CC, Furness JB and Brown KA: Ghrelin
and breast cancer: Emerging roles in obesity, estrogen regulation,
and cancer. Front Oncol. 6:2652017. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Rodríguez A, Gómez-Ambrosi J, Catalán V,
Rotellar F, Valentí V, Silva C, Mugueta C, Pulido MR, Vázquez R,
Salvador J, et al: The ghrelin O-acyltransferase-ghrelin system
reduces TNF-α-induced apoptosis and autophagy in human visceral
adipocytes. Diabetologia. 55:3038–3050. 2012. View Article : Google Scholar
|
|
59
|
Sheriff S, Kadeer N, Joshi R, Friend LA,
James JH and Balasubramaniam A: Des-acyl ghrelin exhibits
pro-anabolic and anti-catabolic effects on C2C12 myotubes exposed
to cytokines and reduces burn-induced muscle proteolysis in rats.
Mol Cell Endocrinol. 351:286–295. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Wu R, Chaung WW, Dong W, Ji Y, Barrera R,
Nicastro J, Molmenti EP, Coppa GF and Wang P: Ghrelin maintains the
cardiovascular stability in severe sepsis. J Surg Res. 178:370–377.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Porporato PE, Filigheddu N, Reano S,
Ferrara M, Angelino E, Gnocchi VF, Prodam F, Ronchi G, Fagoonee S,
Fornaro M, et al: Acylated and unacylated ghrelin impair skeletal
muscle atrophy in mice. J Clin Invest. 123:611–622. 2013.PubMed/NCBI
|
|
62
|
Bouillon-Minois JB, Trousselard M, Thivel
D, Gordon BA, Schmidt J, Moustafa F, Oris C and Dutheil F: Ghrelin
as a biomarker of stress: A systematic review and meta-analysis.
Nutrients. 13:7842021. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Gray SM, Page LC and Tong J: Ghrelin
regulation of glucose metabolism. J Neuroendocrinol. 31:e127052019.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Nass RM, Gaylinn BD, Rogol AD and Thorner
MO: Ghrelin and growth hormone: Story in reverse. Proc Natl Acad
Sci USA. 107:8501–8502. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Quiñones M, Fernø J and Al-Massadi O:
Ghrelin and liver disease. Rev Endocr Metab Disord. 21:45–56. 2020.
View Article : Google Scholar
|
|
66
|
Akalu Y, Molla MD, Dessie G and Ayelign B:
Physiological effect of ghrelin on body systems. Int J Endocrinol.
2020:13851382020. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Tschöp M, Smiley DL and Heiman ML: Ghrelin
induces adiposity in rodents. Nature. 407:908–913. 2000. View Article : Google Scholar
|
|
68
|
Mihalache L, Arhire LI, Giuşcă SE,
Gherasim A, Niţă O, Constantinescu D, Constantinescu RN, Pădureanu
SS and Danciu M: Ghrelin-producing cells distribution in the
stomach and the relation with Helicobacter pylori in obese
patients. Rom J Morphol Embryol. 60:219–225. 2019.PubMed/NCBI
|
|
69
|
Chowen JA and Argente J: Ghrelin: A link
between energy homeostasis and the immune system. Endocrinology.
158:2077–2081. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Dixit VD, Schaffer EM, Pyle RS, Collins
GD, Sakthivel SK, Palaniappan R, Lillard JW Jr and Taub DD: Ghrelin
inhibits leptin- and activation-induced proinflammatory cytokine
expression by human monocytes and T cells. J Clin Invest.
114:57–66. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Kasımay O, Işeri SO, Barlas A, Bangir D,
Yeğen C, Arbak S and Yeğen BC: Ghrelin ameliorates
pancreaticobiliary inflammation and associated remote organ injury
in rats. Hepatol Res. 36:11–19. 2006. View Article : Google Scholar
|
|
72
|
Huang CX, Yuan MJ, Huang H, Wu G, Liu Y,
Yu SB, Li HT and Wang T: Ghrelin inhibits post-infarct myocardial
remodeling and improves cardiac function through anti-inflammation
effect. Peptides. 30:2286–2291. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Chang RJ, Wang HL, Qin MB, Liang ZH, He
JP, Wei YL, Fu HZ and Tang GD: Ghrelin inhibits IKKβ/NF-κB
activation and reduces pro-inflammatory cytokine production in
pancreatic acinar AR42J cells treated with cerulein. Hepatobiliary
Pancreat Dis Int. Jun 2–2020.(Online ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Mao Y, Wang J, Yu F, Cheng J, Li H, Guo C
and Fan X: Ghrelin reduces liver impairment in a model of
concanavalin A-induced acute hepatitis in mice. Drug Des Devel
Ther. 9:5385–5396. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Karmiris K, Koutroubakis IE, Xidakis C,
Polychronaki M, Voudouri T and Kouroumalis EA: Circulating levels
of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel
disease. Inflamm Bowel Dis. 12:100–105. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Theil MM, Miyake S, Mizuno M, Tomi C,
Croxford JL, Hosoda H, Theil J, von Hörsten S, Yokote H, Chiba A,
et al: Suppression of experimental autoimmune encephalomyelitis by
ghrelin. J Immunol. 183:2859–2866. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Granado M, Priego T, Martín AI, Villanúa
MA and López-Calderón A: Anti-inflammatory effect of the ghrelin
agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic
rats. Am J Physiol Endocrinol Metab. 288:E486–E492. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Gonzalez-Rey E, Chorny A and Delgado M:
Therapeutic action of ghrelin in a mouse model of colitis.
Gastroenterology. 130:1707–1720. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Liu H, Luo J, Guillory B, Chen JA, Zang P,
Yoeli JK, Hernandez Y, Lee II, Anderson B, Storie M, et al: Ghrelin
ameliorates tumor-induced adipose tissue atrophy and inflammation
via Ghrelin receptor-dependent and -independent pathways.
Oncotarget. 11:3286–3302. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Lacerda-Miranda G, Soares VM, Vieira AK,
Lessa JG, Rodrigues-Cunha AC, Cortez E, Garcia-Souza EP and Moura
AS: Ghrelin signaling in heart remodeling of adult obese mice.
Peptides. 35:65–73. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Sullivan R, McGirr R, Hu S, Tan A, Wu D,
Charron C, Lalonde T, Arany E, Chakrabarti S, Luyt L and
Dhanvantari S: Changes in the cardiac GHSR1a-ghrelin system
correlate with myocardial dysfunction in diabetic cardiomyopathy in
mice. J Endocr Soc. 2:178–189. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Grossini E, Raina G, Farruggio S, Camillo
L, Molinari C, Mary D, Walker GE, Bona G, Vacca G, Moia S, et al:
Intracoronary des-acyl ghrelin acutely increases cardiac perfusion
through a nitric oxide-related mechanism in female anesthetized
pigs. Endocrinology. 157:2403–2415. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Soeki T, Kishimoto I, Schwenke DO,
Tokudome T, Horio T, Yoshida M, Hosoda H and Kangawa K: Ghrelin
suppresses cardiac sympathetic activity and prevents early left
ventricular remodeling in rats with myocardial infarction. Am J
Physiol Heart Circ Physiol. 294:H426–H432. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Henriques-Coelho T, Correia-Pinto J,
Roncon-Albuquerque R Jr, Baptista MJ, Lourenço AP, Oliveira SM,
Brandão-Nogueira A, Teles A, Fortunato JM and Leite-Moreira AF:
Endogenous production of ghrelin and beneficial effects of its
exogenous administration in monocrotaline-induced pulmonary
hypertension. Am J Physiol Heart Circ Physiol. 287:H2885–H2890.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Wu R, Dong W, Zhou M, Zhang F, Marini CP,
Ravikumar TS and Wang P: Ghrelin attenuates sepsis-induced acute
lung injury and mortality in rats. Am J Respir Crit Care Med.
176:805–813. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
DeBoer MD, Zhu XX, Levasseur P, Meguid MM,
Suzuki S, Inui A, Taylor JE, Halem HA, Dong JZ, Datta R, et al:
Ghrelin treatment causes increased food intake and retention of
lean body mass in a rat model of cancer cachexia. Endocrinology.
148:3004–3012. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Wang W, Andersson M, Iresjö BM, Lönnroth C
and Lundholm K: Effects of ghrelin on anorexia in tumor-bearing
mice with eicosanoid-related cachexia. Int J Oncol. 28:1393–1400.
2006.PubMed/NCBI
|
|
88
|
Bayliss JA, Lemus MB, Stark R, Santos VV,
Thompson A, Rees DJ, Galic S, Elsworth JD, Kemp BE, Davies JS and
Andrews ZB: Ghrelin-AMPK signaling mediates the neuroprotective
effects of calorie restriction in Parkinson's disease. J Neurosci.
36:3049–3063. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Unger MM, Oertel WH and Tackenberg B:
Cerebrospinal fluid concentrations of ghrelin in patients with
multiple sclerosis. Neuro Endocrinol Lett. 34:14–17.
2013.PubMed/NCBI
|
|
90
|
Ngo ST, Steyn FJ, Huang L, Mantovani S,
Pfluger CM, Woodruff TM, O'Sullivan JD, Henderson RD and McCombe
PA: Altered expression of metabolic proteins and adipokines in
patients with amyotrophic lateral sclerosis. J Neurol Sci.
357:22–27. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Cassoni P, Ghé C, Marrocco T, Tarabra E,
Allia E, Catapano F, Deghenghi R, Ghigo E, Papotti M and Muccioli
G: Expression of ghrelin and biological activity of specific
receptors for ghrelin and des-acyl ghrelin in human prostate
neoplasms and related cell lines. Eur J Endocrinol. 150:173–184.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Grönberg M, Fjällskog ML, Jirström K and
Janson ET: Expression of ghrelin is correlated to a favorable
outcome in invasive breast cancer. Acta Oncol. 51:386–393. 2012.
View Article : Google Scholar
|
|
93
|
Sadjadi A, Yazdanbod A, Lee YY, Boreiri M,
Samadi F, Alizadeh BZ, Islami F, Fyfe V, Babaei M, Namazi MJ, et
al: Serum ghrelin; a new surrogate marker of gastric mucosal
alterations in upper gastrointestinal carcinogenesis. PLoS One.
8:e744402013. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Lin TC, Liu YP, Chan YC, Su CY, Lin YF,
Hsu SL, Yang CS and Hsiao M: Ghrelin promotes renal cell carcinoma
metastasis via Snail activation and is associated with poor
prognosis. J Pathol. 237:50–61. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
De Vriese C and Delporte C: Autocrine
proliferative effect of ghrelin on leukemic HL-60 and THP-1 cells.
J Endocrinol. 192:199–205. 2007. View Article : Google Scholar
|
|
96
|
Cassoni P, Papotti M, Ghè C, Catapano F,
Sapino A, Graziani A, Deghenghi R, Reissmann T, Ghigo E and
Muccioli G: Identification, characterization, and biological
activity of specific receptors for natural (ghrelin) and synthetic
growth hormone secretagogues and analogs in human breast carcinomas
and cell lines. J Clin Endocrinol Metab. 86:1738–1745. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Tsubouchi H, Onomura H, Saito Y, Yanagi S,
Miura A, Matsuo A, Matsumoto N and Nakazato M: Ghrelin does not
influence cancer progression in a lung adenocarcinoma cell line.
Endocr J. 64 (Suppl 1):S41–S46. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Duxbury MS, Waseem T, Ito H, Robinson MK,
Zinner MJ, Ashley SW and Whang EE: Ghrelin promotes pancreatic
adenocarcinoma cellular proliferation and invasiveness. Biochem
Biophys Res Commun. 309:464–468. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Jeffery PL, Herington AC and Chopin LK:
Expression and action of the growth hormone releasing peptide
ghrelin and its receptor in prostate cancer cell lines. J
Endocrinol. 172:R7–R11. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Tian C, Zhang L, Hu D and Ji J: Ghrelin
induces gastric cancer cell proliferation, migration, and invasion
through GHS-R/NF-κB signaling pathway. Mol Cell Biochem.
382:163–172. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Waseem T, Javaid-Ur-Rehman, Ahmad F, Azam
M and Qureshi MA: Role of ghrelin axis in colorectal cancer: A
novel association. Peptides. 29:1369–1376. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Lien GS, Lin CH, Yang YL, Wu MS and Chen
BC: Ghrelin induces colon cancer cell proliferation through the
GHS-R, Ras, PI3K, Akt, and mTOR signaling pathways. Eur J
Pharmacol. 776:124–131. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Kraus D, Reckenbeil J, Wenghoefer M, Stark
H, Frentzen M, Allam JP, Novak N, Frede S, Götz W, Probstmeier R,
et al: Ghrelin promotes oral tumor cell proliferation by modifying
GLUT1 expression. Cell Mol Life Sci. 73:1287–1299. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Waseem T, Duxbury M, Ashley SW and
Robinson MK: Ghrelin promotes intestinal epithelial cell
proliferation through PI3K/Akt pathway and EGFR trans-activation
both converging to ERK 1/2 phosphorylatio. Peptides. 52:113–121.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Barzon L, Pacenti M, Masi G, Stefani AL,
Fincati K and Palù G: Loss of growth hormone secretagogue receptor
1a and overexpression of type 1b receptor transcripts in human
adrenocortical tumors. Oncology. 68:414–421. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Fung JN, Seim I, Wang D, Obermair A,
Chopin LK and Chen C: Expression and in vitro functions of the
ghrelin axis in endometrial cancer. Horm Cancer. 1:245–255. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Lawnicka H, Mełeń-Mucha G, Motylewska E,
Mucha S and Stępień H: Modulation of ghrelin axis influences the
growth of colonic and prostatic cancer cells in vitro. Pharmacol
Rep. 64:951–959. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
El-Kott AF, Shati AA, Al-Kahtani MA and
Alqahtani S: Acylated ghrelin renders chemosensitive ovarian cancer
cells resistant to cisplatin chemotherapy via activation of the
PI3K/Akt/mTOR survival pathway. Anal Cell Pathol (Amst).
2019:96278102019.PubMed/NCBI
|
|
109
|
Rincón-Fernández D, Culler MD, Tsomaia N,
Moreno-Bueno G, Luque RM, Gahete MD and Castaño JP: In1-ghrelin
splicing variant is associated with reduced disease-free survival
of breast cancer patients and increases malignancy of breast cancer
cells lines. Carcinogenesis. 39:447–457. 2018. View Article : Google Scholar
|
|
110
|
Hormaechea-Agulla D, Gahete MD,
Jiménez-Vacas JM, Gómez-Gómez E, Ibáñez-Costa A, L-López F,
Rivero-Cortés E, Sarmento-Cabral A, Valero-Rosa J,
Carrasco-Valiente J, et al: The oncogenic role of the In1-ghrelin
splicing variant in prostate cancer aggressiveness. Mol Cancer.
16:1462017. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Chen JH, Huang SM, Chen CC, Tsai CF, Yeh
WL, Chou SJ, Hsieh WT and Lu DY: Ghrelin induces cell migration
through GHS-R, CaMKII, AMPK, and NF-κB signaling pathway in glioma
cells. J Cell Biochem. 112:2931–2941. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Lin TC, Yeh YM, Fan WL, Chang YC, Lin WM,
Yang TY and Hsiao M: Ghrelin upregulates oncogenic Aurora A to
promote renal cell carcinoma invasion. Cancers (Basel). 11:3032019.
View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Tiaka EK, Manolakis AC, Kapsoritakis AN
and Potamianos SP: Unraveling the link between leptin, ghrelin and
different types of colitis. Ann Gastroenterol. 24:20–28.
2011.PubMed/NCBI
|
|
114
|
Ghomraoui FA, Alotaibi ST, Alharthi MA,
Asiri SS, Almadi MA, Alharbi OR, Azzam NA, Aljebreen AM, Saeed M,
Hajkhder B, et al: Plasma ghrelin and leptin in patients with
inflammatory bowel disease and its association with nutritional
status. Saudi J Gastroenterol. 23:199–205. 2017.PubMed/NCBI
|
|
115
|
Omoto I, Matsumoto M, Uchikado Y, Kita Y,
Sakurai T, Sasaki K, Setoyama T, Okumura H, Owaki T, Ishigami S and
Natsugoe S: Immunohistochemical evidence of association between
ghrelin expression and tumor growth in esophageal carcinoma.
Anticancer Res. 34:2727–2733. 2014.PubMed/NCBI
|
|
116
|
Mottershead M, Karteris E, Barclay JY,
Suortamo S, Newbold M, Randeva H and Nwokolo CU:
Immunohistochemical and quantitative mRNA assessment of ghrelin
expression in gastric and oesophageal adenocarcinoma. J Clin
Pathol. 60:405–409. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Murphy G, Kamangar F, Albanes D, Stanczyk
FZ, Weinstein SJ, Taylor PR, Virtamo J, Abnet CC, Dawsey SM and
Freedman ND: Serum ghrelin is inversely associated with risk of
subsequent oesophageal squamous cell carcinoma. Gut. 61:1533–1537.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Pritchett NR, Maziarz M, Shu XO, Kamangar
F, Dawsey SM, Fan JH, Ji BT, Gao YT, Xiang YB, Qiao YL, et al:
Serum ghrelin and esophageal and gastric cancer in two cohorts in
China. Int J Cancer. 146:2728–2735. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
de Martel C, Haggerty TD, Corley DA,
Vogelman JH, Orentreich N and Parsonnet J: Serum ghrelin levels and
risk of subsequent adenocarcinoma of the esophagus. Am J
Gastroenterol. 102:1166–1172. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Thomas SJ, Almers L, Schneider J, Graham
JE, Havel PJ and Corley DA: Ghrelin and leptin have a complex
relationship with risk of Barrett's esophagus. Dig Dis Sci.
61:70–79. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Rubenstein JH, Morgenstern H, McConell D,
Scheiman JM, Schoenfeld P, Appelman H, McMahon LF Jr, Kao JY, Metko
V, Zhang M and Inadomi JM: Associations of diabetes mellitus,
insulin, leptin, and ghrelin with gastroesophageal reflux and
Barrett's esophagus. Gastroenterolog. 145:1237–1244.e1-e5. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Konturek PC, Burnat G, Rau T, Hahn EG and
Konturek S: Effect of adiponectin and ghrelin on apoptosis of
Barrett adenocarcinoma cell line. Dig Dis Sci. 53:597–605. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Xie SH, Rabbani S, Ness-Jensen E and
Lagergren J: Circulating levels of inflammatory and metabolic
biomarkers and risk of esophageal adenocarcinoma and Barrett
esophagus: Systematic review and meta-analysis. Cancer Epidemiol
Biomarkers Prev. 29:2109–2118. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Zhu C, Liu Y, Kang W, Zhang Z, Zeng Z and
Liu D: Exploration of the role of serum ghrelin in the diagnosis
and treatment of digestive tract malignancies. J Int Med Res.
48:3000605209204412020. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Shinsyu A, Bamba S, Kurihara M, Matsumoto
H, Sonoda A, Inatomi O, Andoh A, Takebayashi K, Kojima M, Iida H,
et al: Inflammatory cytokines, appetite-regulating hormones, and
energy metabolism in patients with gastrointestinal cancer. Oncol
Lett. 20:1469–1479. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Chen JH, Zhai ET, Yuan YJ, Wu KM, Xu JB,
Peng JJ, Chen CQ, He YL and Cai SR: Systemic immune-inflammation
index for predicting prognosis of colorectal cancer. World J
Gastroenterol. 23:6261–6272. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Chang WJ, Du Y, Zhao X, Ma LY and Cao GW:
Inflammation-related factors predicting prognosis of gastric
cancer. World J Gastroenterol. 20:4586–4596. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Aydin S, Ozercan IH, Dagli F, Aydin S,
Dogru O, Celebi S, Akin O and Guzel SP: Ghrelin
immunohistochemistry of gastric adenocarcinoma and mucoepidermoid
carcinoma of salivary gland. Biotech Histochem. 80:163–168. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
129
|
An JY, Choi MG, Noh JH, Sohn TS, Jin DK
and Kim S: Clinical significance of ghrelin concentration of plasma
and tumor tissue in patients with gastric cancer. J Surg Res.
143:344–349. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Murphy G, Kamangar F, Dawsey SM, Stanczyk
FZ, Weinstein SJ, Taylor PR, Virtamo J, Abnet CC, Albanes D and
Freedman ND: The relationship between serum ghrelin and the risk of
gastric and esophagogastric junctional adenocarcinomas. J Natl
Cancer Inst. 103:1123–1129. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Nwokolo CU, Freshwater DA, O'Hare P and
Randeva HS: Plasma ghrelin following cure of Helicobacter
pylori. Gut. 52:637–640. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Osawa H, Nakazato M, Date Y, Kita H,
Ohnishi H, Ueno H, Shiiya T, Satoh K, Ishino Y and Sugano K:
Impaired production of gastric ghrelin in chronic gastritis
associated with Helicobacter pylori. J Clin Endocrinol
Metab. 90:10–16. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Zub-Pokrowiecka A, Rembiasz K, Konturek
PC, Budzyński A, Konturek SJ, Winiarski M and Bielański W: Ghrelin
and gastrin in advanced gastric cancer before and after
gastrectomy. World J Gastroenterol. 17:449–458. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Jeon TY, Lee S, Kim HH, Kim YJ, Son HC,
Kim DH and Sim MS: Changes in plasma ghrelin concentration
immediately after gastrectomy in patients with early gastric
cancer. J Clin Endocrinol Metab. 89:5392–5396. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Takachi K, Doki Y, Ishikawa O, Miyashiro
I, Sasaki Y, Ohigashi H, Murata K, Nakajima H, Hosoda H, Kangawa K,
et al: Postoperative ghrelin levels and delayed recovery from body
weight loss after distal or total gastrectomy. J Surg Res. 130:1–7.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Wu X, Wu Y, Ye B, Wu F and Wang P: High
expression of ghrelin and obestatin prepropeptide in tumor tissues
predicted adverse overall survival in gastric carcinoma patients.
Medicine (Baltimore). 99:e206352020. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Wolf I, Sadetzki S, Kanety H, Kundel Y,
Pariente C, Epstein N, Oberman B, Catane R, Kaufman B and Shimon I:
Adiponectin, ghrelin, and leptin in cancer cachexia in breast and
colon cancer patients. Cancer. 106:966–973. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Liu A, Huang C, Xu J and Cai X:
Lentivirus-mediated shRNA interference of ghrelin receptor blocks
proliferation in the colorectal cancer cells. Cancer Med.
5:2417–2426. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Huang Q, Fan YZ, Ge BJ, Zhu Q and Tu ZY:
Circulating ghrelin in patients with gastric or colorectal cancer.
Dig Dis Sci. 52:803–809. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
D'Onghia V, Leoncini R, Carli R, Santoro
A, Giglioni S, Sorbellini F, Marzocca G, Bernini A, Campagna S,
Marinello E and Vannoni D: Circulating gastrin and ghrelin levels
in patients with colorectal cancer: Correlation with tumour stage,
Helicobacter pylori infection and BMI. Biomed Pharmacother.
61:137–141. 2007. View Article : Google Scholar
|
|
141
|
Nikolopoulos D, Theocharis S,
Moutsios-Rentzos A, Kouraklis G and Kostakis A: The role of serum
total ghrelin level elevation in colon cancer patients. J BUON.
19:388–393. 2014.PubMed/NCBI
|
|
142
|
Kemik O, Sumer A, Kemik AS, Hasirci I,
Purisa S, Dulger AC, Demiriz B and Tuzun S: The relationship among
acute-phase response proteins, cytokines and hormones in cachectic
patients with colon cancer. World J Surg Oncol. 8:852010.
View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Murphy G, Cross AJ, Dawsey SM, Stanczyk
FZ, Kamangar F, Weinstein SJ, Taylor PR, Männistö S, Albanes D,
Abnet CC and Freedman ND: Serum ghrelin is associated with risk of
colorectal adenocarcinomas in the ATBC study. Gut. 67:1646–1651.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Sundkvist A, Myte R, Palmqvist R, Harlid S
and Van Guelpen B: Plasma ghrelin is probably not a useful
biomarker for risk prediction or early detection of colorectal
cancer. Gut. 68:373–374. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Coppedè F, Stoccoro A, Lazzarotti A,
Spisni R and Migliore L: Investigation of GHSR and GHRL methylation
in colorectal cancer. Epigenomics. 10:1525–1539. 2018. View Article : Google Scholar
|
|
146
|
Chopin LK, Seim I, Walpole CM and
Herington AC: The ghrelin axis-does it have an appetite for cancer
progression? Endocr Rev. 33:849–891. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Molfino A, Formiconi A, Rossi Fanelli F
and Muscaritoli M: Ghrelin: From discovery to cancer cachexia
therapy. Curr Opin Clin Nutr Metab Care. 17:471–476. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Rindi G, Savio A, Torsello A, Zoli M,
Locatelli V, Cocchi D, Paolotti D and Solcia E: Ghrelin expression
in gut endocrine growths. Histochem Cell Biol. 117:521–525. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Papotti M, Cassoni P, Volante M, Deghenghi
R, Muccioli G and Ghigo E: Ghrelin-producing endocrine tumors of
the stomach and intestine. J Clin Endocrinol Metab. 86:5052–5059.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Raffel A, Krausch M, Cupisti K, Gerharz
CD, Eisenberger CF and Knoefel WT: Ghrelin expression in
neuroendocrine tumours of the gastrointestinal tract with multiple
endocrine neoplasia type 1. Horm Metab Res. 37:653–655. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Ekeblad S, Nilsson B, Lejonklou MH,
Johansson T, Stålberg P, Nilsson O, Ahlman H and Skogseid B:
Gastrointestinal stromal tumors express the orexigen ghrelin.
Endocr Relat Cancer. 13:963–970. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Volante M, Allìa E, Gugliotta P, Funaro A,
Broglio F, Deghenghi R, Muccioli G, Ghigo E and Papotti M:
Expression of ghrelin and of the GH secretagogue receptor by
pancreatic islet cells and related endocrine tumors. J Clin
Endocrinol Metab. 87:1300–1308. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Ekeblad S, Lejonklou MH, Grimfjärd P,
Johansson T, Eriksson B, Grimelius L, Stridsberg M, Stålberg P and
Skogseid B: Co-expression of ghrelin and its receptor in pancreatic
endocrine tumours. Clin Endocrinol (Oxf). 66:115–122.
2007.PubMed/NCBI
|
|
154
|
Tsolakis AV, Stridsberg M, Grimelius L,
Portela-Gomes GM, Falkmer SE, Waldum HL and Janson ET: Ghrelin
immunoreactive cells in gastric endocrine tumors and their relation
to plasma ghrelin concentration. J Clin Gastroenterol. 42:381–388.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Walter T, Chardon L, Hervieu V, Cohen R,
Chayvialle JA, Scoazec JY and Lombard-Bohas C: Major
hyperghrelinemia in advanced well-differentiated neuroendocrine
carcinomas: Report of three cases. Eur J Endocrino. 161:639–645.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Corbetta S, Peracchi M, Cappiello V, Lania
A, Lauri E, Vago L, Beck-Peccoz P and Spada A: Circulating ghrelin
levels in patients with pancreatic and gastrointestinal
neuroendocrine tumors: Identification of one pancreatic ghrelinoma.
J Clin Endocrinol Metab. 88:3117–3120. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Wang HS, Oh DS, Ohning GV and Pisegna JR:
Elevated serum ghrelin exerts an orexigenic effect that may
maintain body mass index in patients with metastatic neuroendocrine
tumors. J Mol Neurosci. 33:225–231. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
van Adrichem RC, van der Lely AJ, Huisman
M, Kramer P, Feelders RA, Delhanty PJ and de Herder WW: Plasma
acylated and plasma unacylated ghrelin: Useful new biomarkers in
patients with neuroendocrine tumors? Endocr Connect. 5:143–151.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Luque RM, Sampedro-Nuñez M, Gahete MD,
Ramos-Levi A, Ibáñez-Costa A, Rivero-Cortés E, Serrano-Somavilla A,
Adrados M, Culler MD, Castaño JP and Marazuela M: In1-ghrelin, a
splice variant of ghrelin gene, is associated with the evolution
and aggressiveness of human neuroendocrine tumors: Evidence from
clinical, cellular and molecular parameters. Oncotarget.
6:19619–19633. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Herrera-Martínez AD, Gahete MD,
Sánchez-Sánchez R, Alors-Perez E, Pedraza-Arevalo S, Serrano-Blanch
R, Martínez-Fuentes AJ, Gálvez-Moreno MA, Castaño JP and Luque RM:
Ghrelin-O-acyltransferase (GOAT) enzyme as a novel potential
biomarker in gastroenteropancreatic neuroendocrine tumors. Clin
Transl Gastroenterol. 9:1962018. View Article : Google Scholar
|
|
161
|
Hirota S: Differential diagnosis of
gastrointestinal stromal tumor by histopathology and
immunohistochemistry. Transl Gastroenterol Hepatol. 3:272018.
View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Doyle LA and Hornick JL: Gastrointestinal
stromal tumours: From KIT to succinate dehydrogenase.
Histopathology. 64:53–67. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Zhu CZ, Liu D, Kang WM, Yu JC, Ma ZQ, Ye X
and Li K: Ghrelin and gastrointestinal stromal tumors. World J
Gastroenterol. 23:1758–1763. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Ghè C, Cassoni P, Catapano F, Marrocco T,
Deghenghi R, Ghigo E, Muccioli G and Papotti M: The
antiproliferative effect of synthetic peptidyl GH secretagogues in
human CALU-1 lung carcinoma cells. Endocrinology. 143:484–491.
2002. View Article : Google Scholar
|
|
165
|
Alnema MM, Aydin S, Ozkan Y, Dagli AF,
Ozercan HI, Yildirim N, Sahin I, Karaoglu A, Kilic N, Yilmaz M, et
al: Ghrelin and obestatin expression in oral squamous cell
carcinoma: An immunohistochemical and biochemical study. Mol Cell
Biochem. 339:173–179. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Lou J, Liu L, Zhang W, Zhou Z and Fan Y:
Differential expression of ghrelin and GHSR via the mTOR pathway
during the dynamic carcinogenic process involving oral, potentially
malignant disorders. Biosci Rep. 39:BSR201921022019. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Dagli AF, Aydin S, Karaoglu A, Akpolat N,
Ozercan IH and Ozercan MR: Ghrelin expression in normal kidney
tissue and renal carcinomas. Pathol Res Pract. 205:165–173. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Grönberg M, Amini RM, Stridsberg M, Janson
ET and Saras J: Neuroendocrine markers are expressed in human
mammary glands. Regul Pept. 160:68–74. 2010. View Article : Google Scholar
|
|
169
|
Grönberg M, Nilsson C, Markholm I,
Hedenfalk I, Blomqvist C, Holmberg L, Tiensuu Janson E and
Fjällskog ML: Ghrelin expression is associated with a favorable
outcome in male breast cancer. Sci Rep. 8:135862018. View Article : Google Scholar
|
|
170
|
Malendowicz W, Ziolkowska A, Szyszka M and
Kwias Z: Elevated blood active ghrelin and unaltered total ghrelin
and obestatin concentrations in prostate carcinoma. Urol Int.
83:471–475. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Fung JN, Jeffery PL, Lee JD, Seim I, Roche
D, Obermair A, Chopin LK and Chen C: Silencing of ghrelin receptor
expression inhibits endometrial cancer cell growth in vitro and in
vivo. Am J Physiol Endocrinol Metab. 305:E305–E313. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Kerenidi T, Lada M, Tsaroucha A,
Georgoulias P, Mystridou P and Gourgoulianis KI: Clinical
significance of serum adipokines levels in lung cancer. Med Oncol.
30:5072013. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Li X, Zhao X, Li C, Liu S, Yan F, Teng Y,
Feng J and Miao D: Inhibitor of ghrelin receptor reverses gefitinib
resistance in lung cancer. Hum Cell. 32:360–366. 2019. View Article : Google Scholar : PubMed/NCBI
|
